CD274 and neoplasm: One unanticipated finding was that in our cohort none of the detected NSCLC CTCs had PD-L1 expression, despite 65.2% of the cohort having PD-L1-positive tumours (> 1%), with 36.5% with more than 50% tumour specific staining.